Larvol Delta - A-Study-of-ONO4538HSC-in-Pediatric-Patients-With-Malignant-Solid-Tumors-and-in-Patients-With-Epithelioid-Sarcoma

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) - BMS, Ono Pharmaceutical

http://clinicaltrials.gov/ct2/show/NCT07734116

Sep 9, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next